The downregulation of PTEN activates the PI3K/Akt and STAT3 signaling, resulting in increased accumulation of cancer-promoting molecules like IL-10, CCL2, and VEGF-A, while simultaneously reducing the antitumor immune response (110). This evidence concerns the gene PTEN and cancer.